These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27812135)

  • 1. Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.
    Thiébaut R; Esmiol S; Lecine P; Mahfouz B; Hermant A; Nicoletti C; Parnis S; Perroy J; Borg JP; Pascoe L; Hugot JP; Ollendorff V
    PLoS One; 2016; 11(11):e0165420. PubMed ID: 27812135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NOD2-RICK complex signals from the plasma membrane.
    Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
    J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion.
    Warner N; Burberry A; Pliakas M; McDonald C; Núñez G
    J Biol Chem; 2014 Oct; 289(41):28213-24. PubMed ID: 25170077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.
    Schaefer AK; Wastyk HC; Mohanan V; Hou CW; Lauro ML; Melnyk JE; Burch JM; Grimes CL
    Biochemistry; 2017 Aug; 56(34):4445-4448. PubMed ID: 28792733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease.
    Pugazhendhi S; Santhanam S; Venkataraman J; Creveaux I; Ramakrishna BS
    Gene; 2013 Jan; 512(2):309-13. PubMed ID: 23085276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
    Stevens C; Henderson P; Nimmo ER; Soares DC; Dogan B; Simpson KW; Barrett JC; ; Wilson DC; Satsangi J
    Gut; 2013 May; 62(5):695-707. PubMed ID: 22684479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.
    Nimmo ER; Stevens C; Phillips AM; Smith A; Drummond HE; Noble CL; Quail M; Davies G; Aldhous MC; Wilson DC; Satsangi J
    Gastroenterology; 2011 Sep; 141(3):972-981.e1-2. PubMed ID: 21699783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
    Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
    Yao Q
    Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.
    Zucchelli M; Torkvist L; Bresso F; Halfvarson J; Hellquist A; Anedda F; Assadi G; Lindgren GB; Svanfeldt M; Janson M; Noble CL; Pettersson S; Lappalainen M; Paavola-Sakki P; Halme L; Färkkilä M; Turunen U; Satsangi J; Kontula K; Löfberg R; Kere J; D'Amato M
    Inflamm Bowel Dis; 2009 Oct; 15(10):1562-9. PubMed ID: 19462432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Rare Missense Variation of the
    Frade-Proud'Hon-Clerc S; Smol T; Frenois F; Sand O; Vaillant E; Dhennin V; Bonnefond A; Froguel P; Fumery M; Guillon-Dellac N; Gower-Rousseau C; Vasseur F
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.
    Marinis JM; Homer CR; McDonald C; Abbott DW
    J Biol Chem; 2011 Jan; 286(3):1938-50. PubMed ID: 21097508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
    Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
    Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.
    Kuenzig ME; Yim J; Coward S; Eksteen B; Seow CH; Barnabe C; Barkema HW; Silverberg MS; Lakatos PL; Beck PL; Fedorak R; Dieleman LA; Madsen K; Panaccione R; Ghosh S; Kaplan GG
    EBioMedicine; 2017 Jul; 21():188-196. PubMed ID: 28668336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
    Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
    Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of NOD2 with Crohn's disease in a homogenous Irish population.
    Bairead E; Harmon DL; Curtis AM; Kelly Y; O'Leary C; Gardner M; Leahy DT; Vaughan P; Keegan D; O'Morain C; O'Donoghue D; Shanahan F; Parfrey NA; Quane KA
    Eur J Hum Genet; 2003 Mar; 11(3):237-44. PubMed ID: 12673278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.